.png)
All marketing authorization holders of medicine are hereby informed that NMRA would not register new applications, renew or issue import license for existing Silodosin Capsules.
(Date: 07 September 2022)
National Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka